Down's syndrome

Lancet

Volumn 361, Issue 9365, 2003, Pages 1281-1289

  Roizen, Nancy J ^a,c   Patterson, David ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY OF DENVER   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; PIRACETAM; REACTIVE OXYGEN METABOLITE;

AGGRESSION; AGITATION; ALZHEIMER DISEASE; AMNIOCENTESIS; APPETITE DISORDER; ARTHRITIS; ATLANTOAXIAL DISLOCATION; AUTISM; BEHAVIOR; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CELIAC DISEASE; CHROMOSOME 21; CLINICAL TRIAL; CONFERENCE PAPER; COUNSELING; DEATH; DEPRESSION; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DISEASE ASSOCIATION; DOWN SYNDROME; FETUS (ANATOMY); GENE LOCATION; HUMAN; HYPOTHYROIDISM; LEUKEMIA; MEDICAL CARE; MENTAL DISEASE; MONITORING; NEUROPATHOLOGY; NUTRITION; OBESITY; PERIODONTAL DISEASE; PHENOTYPE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; QUALITY OF LIFE; SEIZURE; SEXUAL AROUSAL; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SOCIAL PSYCHOLOGY;

EID: 0037433652     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12987-X     Document Type: Conference Paper

References (127)

1. Lejeune J., Gautier M., Turpin R. Etude des chromosomes somatiques de neuf enfants mongoliens. Compte Rendu d'Acad Sci. 248:1959;1721-1722.
2. Hattori M., Fujiyama A., Taylor T.D., et al. The DNA sequence of human chromosome 21. Nature. 405:2000;311-319.
3. Kapranov, Cawley S.E., Drenkow J., et al. Large-scale transcriptional activity in chromosomes 21 and 22. Science. 296:2002;916-919.
4. Capone G., Kim P., Jovanovich S., et al. Evidence for increased mitochrondrial superoxide production in Down syndrome. Life Sci. 70:2002;2885-2895.
5. Busciglio J., Pelsman A., Wong C., et al. Altered metabolism of the amyloid B precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron. 33:2002;677-688.
6. Capone G.T. Down syndrome: advances in molecular biology and the neurosciences. J Dev Behav Pediatr. 22:2001;40-59.
7. Schupf N., Sergievsky G.H. Genetic and host factors for dementia in Down's syndrome. Br J Psychiatry. 180:2002;405-410.
8. Hobbs C.A., Sherman S.L., Yi P., et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet. 67:2000;623-630.
9. O'Leary V.B., Parle-McDermott A., Molloy A.M., et al. MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet. 107:2002;151-155.
10. Hassold T., Sherman S. Down syndrome: genetic recombination and the origin of the extra chromosome 21. Clin Genet. 57:2000;95-100.
11. Kraus J.P., Janosik M., Kozich V., et al. Cystathionine beta-synthase mutations in homocystinuria. Human Mutation. 13:1999;362-375.
12. Bourc'his D., Xu G.L., Lin C.S., Bollman B., Bestor T.H. Dnmt3L and the establishment of maternal genomic imprints. Science. 294:2001;2536-2539.
13. Moscow J.A., Gong M., He R., et al. Isolation of a gene encoding human reduced folate carrier (RFC1) and analysis of its expression in transport deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 55:1995;3790-3794.
14. Solans A., Estivill X., de la Luna S. Cloning and characterization of human FTCD on chromosome 21q22.3, a candidate gene for glutamine formiminotransferase deficiency. Cytogenet Cell Genet. 88:2000;43-49.
15. Katsanis N., Yaspo M.L., Fisher E.M.C. Identification and mapping of a novel human gene, HRMT1L1, homologous to the rat protein arginine N-methyltransferase 1 (PRMT1) gene. Mamm Genome. 8:1997;526-529.
16. Doolin M.T., Barbaux S., McDonnell M., et al. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet. 71:2002;1222-1226.
17. Davisson M.T., Bechtel L.J., Akeson E.C., Fortna A., Slavov D., Gardiner K. Evolutionary breakpoints on human chromosome 21. Genomics. 78:2001;99-106.
18. Reeves R.H., Irving N.G., Moran T., et al. A mouse model for Down syndrome exhibits learning and behavior deficits. Nature Genet. 11:1995;177-183.
19. Hyde L.A., Frisone D.F., Crnic L.S. Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function. Behav Brain Res. 118:2001;53-60.
20. Rechtsmeier J.T., Baxter L.L., Reeves R.H. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev Dynam. 217:2000;137-145.
21. Hyde L.A., Crnic L.S. Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease. Behav Neurosci. 115:2001;1239-1246.
22. Roizen N.J. Down syndrome. Batshaw M.L. Children with Disabilities. 2002;307-320 Brookes, Baltimore.
23. Yaron Y., Mashiach R. First-trimester biochemical screening for Down syndrome. Clin Perinat. 28:2001;321-331.
24. Roizen N.J. Down syndrome: progress in research. Ment Retard Devel Disab Res Rev. 7:2001;39-44.
25. Smith-Bindman R. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis. JAMA. 285:2001;1044-1055.
26. Bianchi D.W. Review fetal cells in the maternal circulation: feasibility for prenatal diagnosis. Br J Haematol. 105:1999;574-583.
27. Blake D., Tan S.L., Ao A. Assessment of multiplex fluorescent PCR for screening single cells for trisomy 21 and single gene defects. Mol Hum Reprod. 5:1999;1166-1175.
28. Hunter A.G.W. Down syndrome. Cassidy S.B., Allanson J.E. Management of genetic syndromes. 2001;103-129 Wiley-Liss, New York.
29. Morris J.K., Mutton D.E., Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. Physiol Res. 49:2000;227-231.
30. Julian-Reynier C., Aurran Y., Dumaret A., et al. Attitudes towards Down's syndrome: follow up of a cohort of 280 cases. J Med Genet. 32:1995;597-599.
31. Lai F.M., Woo B.H., Tan K.H., et al. Birth prevalence of Down syndrome in Singapore from 1993 to 1998. Singapore Med J. 43:2002;70-76.
32. Rosch C., Steinbicker V., Kropf S. Down's syndrome: the effects of prenatal diagnosis and demographic factors in a region of the eastern part of Germany. Europ J Epidem. 16:2000;627-632.
33. Merrick J. Incidence and mortality of Down syndrome. Israel Med Assoc J. 2:2000;25-26.
34. Cheffins T., Chan A., Haan E.A., et al. The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia. Bjog. 107:2000;1453-1459.
35. Olsen C.L., Cross P.K. Trends in the use of prenatal diagnosis in New York State and the impact of biochemical screening on the detection of Down syndrome. Prenat Diagn. 17:1997;1113-1124.
36. Health supervision for children with Down syndrome. Pediatrics. 107:2001;442-449.
37. Cohen W.I. Health care guidelines for individuals with Down syndrome: 1999 revision. Down Syndrome Quar. 4:1999;1-15.
38. Roizen N.J. Medical care and monitoring for the adolescent with Down syndrome. Adolesc Med State of the Art Reviews. 13:2002;345-358.
39. Smith D.S. Health care management of adults with Down syndrome. Am Fam Physician. 64:2001;1031-1040.
40. Freeman S.B., Taft L.F., Dooley K.J., et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet. 80:1998;213-217.
41. Geggel R.L., O'Brien J.E., Feingold M. Development of valve dysfunction in adolescents and young adults with Down syndrome and no known congenital heart disease. J Pediatr. 122:1993;821-823.
42. Marino B., Digilio C.M., Di Donato R. Health supervision for children with Down syndrome. Pediatrics. 108:2001;1384-1385.
43. Roizen N.J., Walters C.A., Nicol T.G., Blondis T.A. Auditory brainstem evoked response in children with Down syndrome. J Peds. 123:1993;S9-S12.
44. Dahle A.J., McCollister F.D. Hearing and otologic disorders in children with Down syndrome. J Ment Defic Res. 32:1988;333-336.
45. Balkany T.J., Downs M.P., Jafek B.W., Krajicek M.J. Hearing loss in Down's syndrome. Clin Ped. 18:1979;116-118.
46. Selikowitz M. Short-term efficacy of tympanostomy tubes for secretory otitis media in children with Down syndrome. Dev Med Child Neurol. 35:1993;511-515.
47. Ilno Y. Efficacy of tympanostomy tube insertion for otitis media with effusion in children with Down syndrome. Int J Pediatr Otorhinolaryngol. 49:1999;143-149.
48. Shott S.R., Joseph A., Heithaus D. Hearing loss in children with Down syndrome. Int J Pediatr Otorhinolaryngol. 61:2001;199-205.
49. Roizen N.J., Mets M.B., Blondis T.A. Ophthalmic disorders in children with Down syndrome. Dev Med Child Neurol. 36:1994;594-600.
50. Catalano R.A. Down syndrome. Surv of Ophthalmol. 34:1990;385-398.
51. Caputo A.R., Wagner R.S., Reynolds D.R., Guo S., Goel A.K. Down syndrome: clinical review of ocular features. Clin Pediatr. 28:1989;355-358.
52. DaCunha R.P., Moreira J.B. Ocular findings in Down's syndrome. Am J Ophthal. 122:1996;236-244.
53. Luke A., Roizen N.J., Sutton M., Schoeller D.A. Energy expenditure in children with Down syndrome: correcting metabolic rate for movement. J Pediatr. 125:1994;829-838.
54. Allison D.B., Gomez J.E., Heshka S., et al. Decreased resting metabolic rate among persons with Down syndrome. Internat J Obesity. 19:1995;858-861.
55. Rubin S.S., Rimmer J.H., Chicoine B., Braddock D., McGuire D.E. Overweight prevalence in persons with Down syndrome. Ment Retard. 36:1998;175-181.
56. Cronk C., Crocker A.C., Pueschel S.M., et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics. 81:1988;102-110.
57. Fujiura G.T., Fitzsimons N., Marks B. Predictors of BMI among adults with Down syndrome: the social context of health promotion. Res Devel Disab. 18:1997;261-274.
58. Sepulveda D., Allison D.B., Gomez J.E., et al. Low spinal and pelvic bone mineral density among individuals with Down syndrome. Am J Ment Retar. 100:1995;109-114.
59. Hennequin M., Faulks D., Veyrune J.-L., Bourdoil P. Significance of oral health in persons with Down syndrome: a literature review. Devel Med Child Neurol. 41:1999;275-283.
60. Carlsson A.K., Axelsson I.E.M., Borulf S.K., Bredberg A.C.A., Ivarsson S.-A. Serological screening for celiac disease in healthy 2·5-year-old children in Sweden. Pediatrics. 107:2001;42-44.
61. Carnicer J., Farre C., Varea V., Vilar P., Moreno J., Artigas J. Prevalence of coeliac disease in Down's syndrome. Eur J Gastroenterol Hepatol. 13:2001;263-267.
62. Book L., Hart A., Black J., Feolo M., Zone J.J., Neuhausen S.L. Prevalence and clinical characteristics of celiac disease in Downs syndrome in a U.S. study. Am J Med Genet. 98:2001;70-74.
63. Zachor D.A., Mroczek-Musulman E., Brown P. Prevalence of celiac disease in Down syndrome in the United States. J Pediatr Gastroenterol Nutr. 31:2000;275-279.
64. Bonamico M., Mariani P., Danesi H.M., et al. Prevalence and clinical picture of celiac disease in Italian Down syndrome patients: a multicenter study. J Pediatr Gastroenterol Nutr. 33:2001;139-143.
65. Karlsson B., Gustafsson J., Hedov G., Ivarsson S.A., Anneren G. Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child. 79:1998;242-245.
66. Fort P., Lifshitz F., Bellisario R., et al. Abnormalities of thyroid function in infants with Down syndrome. J Pediatr. 104:1984;545-549.
67. Kennedy R.L., Jones T.H., Cuckle H.S. Down's syndrome and the thyroid. Clin Endocrinol. 37:1992;471-476.
68. Noble S.E., Leyland K., Findlay C.A., et al. School based screening for hypothyroidism in Down's syndrome by dried blood spot TSH measurement. Arch Dis Child. 82:2000;27-31.
69. McAloon J., Corrigan N. Controversy in thyroid disease. J R Coll Physicians Lond. 34:2000;587.
70. Selikowitz M. A five-year longitudinal study of thyroid function in children with Down syndrome. Dev Med Child Neurol. 35:1993;396-401.
71. Olson J.C., Bender J.C., Levinson J.E., Oestreich A., Lovell D.J. Arthropathy of Down syndrome. Pediatrics. 86:1990;931-936.
72. Ihnat D.H.K., McIlvain-Simpson G., Conard K., Scott C.I., Singsen B.H. Inflammatory arthropathies in children with chromosomal abnormalities. J Rheumatol. 20:1993;742-746.
73. Pant S.S., Moser H.W., Krane S.M. Hyperuricemia in Down's syndrome. J Clin Endocrinol Metab. 28:1968;472-478.
74. Kamatani N., Yamanaka H., Totokawa S., Kashiwazaki S. Down syndrome with coexistent gout: report of six patients and possible reasons for the scarcity of descriptions of this association. Ann Rheum Dis. 55:1996;649-650.
75. Cohen W.I. Atlantoaxial instability: what's next? Arch Pediatr Adolesc Med. 152:1998;119-122.
76. Pueschel S.M. Should children with Down syndrome be screened for atlantoaxial instability? Arch Pediatr Adolesc Med. 152:1998;123-125.
77. Selby K.A., Newton R.W., Gupta S., Hunt L. Clinical predictors and radiological reliability in atlantoaxial subluxation in Down's syndrome. Arch Dis Child. 66:1991;876-878.
78. Atlantoaxial instability in Down syndrome: subject review. Pediatrics. 96:1995;151-153.
79. Cremers M.J.G., Bol E., de Roos F., Van Giin J. Risk of sports activities in children with Down's syndrome and atlantoaxial instability. Lancet. 342:1993;511-514.
80. Pueschel S.M., Scola F.H., Pezzullo J.C. A longitudinal study of atlanto-dens relationships in asymptomatic individuals with Down syndrome. Pediatrics. 89:1992;1194-1198.
81. Taggard D.A., Menezes A.H., Ryken T.C. Treatment of Down syndrome-associated craniovertebral junction abnormalities. J Neurosurg. 93:(suppl 2):2000;205-213.
82. Doyle J.S., Lauerman W.C., Wood K.B., Krause D.R. Complications and long-term outcome of upper cervical spine arthrodesis in patients with Down syndrome. Spine. 21:1996;1223-1231.
83. Anwar A.J., Walker J.D., Frier B.M. Type I diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet Med. 15:1998;160-163.
84. Kivivuori S.M., Rajantie J., Siimes M.A. Peripheral blood cell counts in infants with Down's syndrome. Clinical Genetics. 49:1996;15-19.
85. Roizen N.J., Amarose A.P. Hematologic abnormalities in children with Down syndrome. Am J Med Genet. 46:1993;510-512.
86. Lange B. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol. 110:2000;512-524.
87. Shott S.R. Down syndrome: common pediatric ear, nose, and throat problems. Down Syndrome Quar. 5:2000;1-6.
88. Pueschel S.M., Louis S., McKnight P. Seizure disorders in Down syndrome. Arch Neurol. 48:1991;318-320.
89. Goldberg-Stern H., Strawsburg R.H., Patterson B., et al. Seizure frequency and characteristics in children with Down syndrome. Brain Dev. 23:2001;375-378.
90. Stafstrom C.E., Konkol R.J. Infantile spasms in children with Down syndrome. Devel Med Child Neurol. 36:1994;576-585.
91. Goldstein H. Menarche, menstruation, sexual relations and contraception of adolescent females with Down syndrome. European J Obst Gyn Reprod Bio. 27:1988;343-349.
92. Pueschel S.M., Orson J.M., Boylan J.M., Pezzullo J.C. Adolescent development in males with Down syndrome. AJDC. 139:1985;236-238.
93. Bovicelli L., Orsini L.F., Rizzo N., et al. Reproduction in Down syndrome. Obstet Gynecol. 59:1982;13S.
94. Sheridan R., Llerena J. Jr, Matkins S., Debenham P., Cawood A., Bobrow M. Fertility in male with trisomy 21. J Med Genet. 26:1989;294-298.
95. Elkins T.E., McNeeley S.G., Punch M., Kope S., Heaton C. Reproductive Health Concerns in Down syndrome: a report of eight cases. J Reprod Med. 35:1990;745-750.
96. Schuypf N., Zigman W., Kapell D., Lee J.H., Kline J., Levin B. Early menopause in women with Down syndrome. J Intell Disabil Res. 41:1997;264-267.
97. Ercis M., Balci S., Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 50:1996;317-320.
98. Pueschel S.M. Clinical aspects of Down syndrome from infancy to adulthood. Am J Med Genet. 7:1990;52-56.
99. Scherbenske J.M., Benson P.M., Rotchford J.P., James W.D. Cutaneous and ocular manifestations of Down syndrome. J Am Acad Derm. 22:1990;933-938.
100. Caselli M.A., Cohen-Sobel E., Thompson J., Adler J., Gonzalez L. Biomechanical management of children and adolescents with Down syndrome. J Am Podiatr Med Assoc. 81:1991;119-127.
101. Brown F.R., Greer M.K., Aylward E.H., Hunt H.H. Intellectual and adaptive functioning in individuals with Down syndrome in relation to age and environmental placement. Pediatrics. 85:1990;450-452.
102. Wishart J.G. Cognitive abilities in children with Down syndrome: developmental instability and motivational deficits. Epstein C.J., Hassold T., Lott I.T., et al. Etiology and pathogenesis of Down syndrome. 1995;57-91 Wiley-Liss, New York.
103. Chapman R.S., Seung H.-K., Schwartz S.E., Kay-Raining Bird E. Language skills of children and adolescents with Down syndrome II: production deficits. J Speech Lang Hear Res. 41:1998;861-873.
104. Myers B.A., Pueschel S.M. Psychiatric disorders in a population with Down syndrome. J Nerv Ment Dis. 179:1991;609-613.
105. Kent L., Evans J., Paul M., Sharp M. Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol. 41:1999;153-158.
106. Rasmussen P., Borjesson O., Wentz E., Gillberg C. Autistic disorders in Down syndrome: background factors and clinical correlates. Dev Med Child Neurol. 43:2001;750-754.
107. Howlin P., Wing L., Gould J. The recognition of autism in children with Down syndrome - implications for intervention and some speculations about pathology. Dev Med Child Neurol. 37:1995;398-414.
108. Dalton A.J., Crapper-McLachlan D.R. Clinical expression of Alzheimer's disease in Down syndrome. Psychiatr Clin North Am. 9:1986;959-970.
109. Cooper S.A., Collacott R.A. Clinical features and diagnostic criteria of depression in Down's syndrome. Br J Psychiatry. 165:1994;399-403.
110. Ani C., Grantham-McGregor S., Muller D. Nutritional supplementation in Down syndrome: theoretical considerations and current status. Dev Med Child Neurol. 42:2000;207-213.
111. Lobaugh N.J., Karaskov V., Rombough V., et al. Piracetam therapy does not enhance cognitive functioning in children with Down syndrome. Arch Pediatr Adolesc Med. 155:2001;442-448.
112. Leonard S., Bower Ck, Petterson B., Leonard H. Survival of infants born with Down's syndrome: 1980-96. Paediatr Perinat Epid. 14:2000;163-171.
113. Yang Q., Rasmussen S.A., Friedman J.M. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet. 359:2002;1019-1025.
114. Hasle H., Clemmensen I.H., Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet. 355:2000;165-169.
115. Eyman R.K., Call T.L., White J.F. Life expectancy of persons with Down syndrome. Am J Men Retar. 95:1991;603-612.
116. Bruni M. Fine motor skills in children with Down syndrome: a guide for parents and professionals. 1998;Woodbine House, Bethesda.
117. Hanson M.J. Teaching the infant with Down syndrome: a guide for parents and professionals. 1987;Pro-ed, Austin.
118. Hassold T., Patterson D. Down syndrome: a promising future, together. 1998;Wiley-Liss, New York.
119. Kumin L. Communication skills in children with Down syndrome: a guide for parents. 1994;Woodbine House, Bethesda.
120. Miller J., Leddy M., Leavitt L.A. Improving the communication of people with Down syndrome. 1999;Paul H Brookes, Baltimore.
121. Oelwein P. Teaching reading to children with Down syndrome: a guide for parents and teachers. 1997;Woodbine House, Bethesda.
122. Pueschel S.M. The young person with Down syndrome: transition from adolescence to adulthood. 1988;Paul H Brookes, Baltimore.
123. Roizen N.J. Down syndrome. Batshaw M.L. When your child has a disability. 2001;217-229 Paul H Brookes, Baltimore.
124. Stray-Gundersen K. Babies with Down syndrome: a new parent's guide. 2nd edn: 1995;Woodbine House, Bethesda.
125. Winders P.C. Gross motor skills in children with Down syndrome: a guide for parents and professionals. 1997;Woodbine House, Bethesda.
126. Pueschel S.M. Young people with Down syndrome: transition from childhood to adulthood. Ment Retard Devel Disab Res Rev. 2:1996;90-95.
127. Turnbull A.P., Turnbull H.R. Developing independence. J Adolesc Health Care. 6:1985;108-119.